Bisgaier Charles PhD 4
4 · Gemphire Therapeutics Inc. · Filed Aug 2, 2017
Insider Transaction Report
Form 4
Bisgaier Charles PhD
DirectorChair & Chief Scientific Off.10% Owner
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2017-07-31−4,474→ 0 totalExercise: $1.34From: 2015-06-29Exp: 2025-06-28→ Common Stock (4,474 underlying) - Exercise/Conversion
Common Stock
2017-07-31$1.34/sh+4,474$6,013→ 1,248,914 total
Holdings
- 19,228(indirect: By LLC)
Common Stock
- 82,220(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]These shares are indirectly owned by the reporting person as trustee of The Charles L. Bisgaier Trust.